Tissue Genomic DNA, Pancreas
CNY 1990.00
Cited in 1 publication. |
CNY 6460.00
CNY 9410.00
Specifications
Product Data | |
Disease State | Normal |
Diagnosis Category | Normal |
Tissue | Pancreas |
Frozen Sample ID | FR0001C579 |
Case ID | CU0000006344 |
Prep | B |
Vial ID | DN00000709 |
Tissue of Origin | Pancreas |
Site of Finding | Pancreas |
Appearance | Normal |
Sample Diagnosis (from Pathology Verification) | Within normal limits |
Normal | 100% |
Lesional | 0% |
Tumor | 0% |
Tumor Hypo/Acellular Stroma | 0% |
Tumor Hypercellular Stroma | 0% |
Necrosis | 0% |
Pathology Verification notes from H&E review | normal component contains 80% exocrine epithelium, 2% endocrine epithelium. 18% stroma |
Bioanalyzer Ratio (28S/18S) | 2 |
CASE Diagnosis (from medical center path report) | Adenocarcinoma of pancreas, ductal |
Age | 50 |
Gender | Male |
Tumor Grade | Not applicable |
Minimum Stage Grouping | Not applicable |
T (Extent of Primary Tumor) | Not applicable |
N (Lymph node metastasis) | Not applicable |
M (Distant metastasis) | Not applicable |
Citations (1)
The use of this Tissues has been cited in the following citations: |
---|
Loss of the transcriptional repressor TGIF1 results in enhanced Kras-driven development of pancreatic cancer
,Weng, CC;Hsieh, MJ;Wu, CC;Lin, YC;Shan, YS;Hung, WC;Chen, LT;Cheng, KH;,
Mol. Cancer
,PubMed ID 31109321
[Pancreas]
|
Documents
SDS |